New research published in May indicates a possible connection between B cells and the occurrence of systemic lupus erythematosus symptoms.
Plaquenil: From Malaria Treatment to Managing Lupus, RA
In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…
2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
Atherosclerosis Insights May Shed Light on Lupus
New research compares pathogenic immune response in SLE with immune response that contributes to atherosclerotic plaque
Seizures in Lupus
Case report highlights important twist to differential diagnosis of neuropsychiatric lupus
Case Report: Contagious Rash in Active Systemic Lupus Erythematosus
Consider a diagnosis of crusted scabies in immunosuppressed patients who develop a persistent, pruritic rash
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Proptosis in Systemic Lupus Erythematosus
Diagnosing orbital disease in patients with rheumatic conditions
2014 ACR/ARHP Annual Meeting: Predicting Outcomes for Patients with Lupus Nephritis
Better understanding of kidney inflammation and fibrosis in LN, along with finding novel disease biomarkers could help rheumatologists gauge patients’ response to therapy
Nurses’ Health Study Continues to Offer Valuable Patient Data
Nurses’ cohort of 38 years provides wealth of patient information, research for rheumatologists
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 45
- Next Page »